This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Delivered as Hybrid Event from 16-18 November 2022
Live In-Person Conference Delivered 16-18 NovemberAustria Center Vienna

Jill Caswell, PhD
Biology Team Leader at Almac Sciences

Profile

Dr Jill Caswell is the Biology Team Leader within Almac’s Biocatalysis group. After obtaining a degree in Biochemistry Jill worked in industry producing recombinant proteins in a variety of host organisms before obtaining a PhD in 2011 through an industrial collaboration with Queen’s University Belfast. Jill’s career has focussed on recombinant enzyme expression as well as molecular biology techniques that enable enzyme engineering. She joined Almac’s Biocatalysis group in 2012 with 10 years of industrial relevant experience to bring to the biology team helping to grow the enzyme engineering capabilities. In more recent years, she has worked with the Biocatalysis team to develop enzymatic oligonucleotide synthesis technology.

Agenda Sessions

  • Technology for Biocatalytic Synthesis of Oligonucleotides

    16:30